• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估心力衰竭伴射血分数保留患者中心肌淀粉样变作为潜在潜在病因的临床特征。

Assessment of clinical characteristics of cardiac amyloidosis as a potential underlying etiology in patients diagnosed with heart failure with preserved ejection fraction.

机构信息

Department of Cardiology, Eskisehir Osmangazi University, Eskisehir, Turkey.

Department of Nuclear Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey.

出版信息

Kardiol Pol. 2022;80(6):672-678. doi: 10.33963/KP.a2022.0098. Epub 2022 Apr 7.

DOI:10.33963/KP.a2022.0098
PMID:35390167
Abstract

BACKGROUND

Heart failure with preserved ejection fraction (HFpEF) is heterogeneous clinical syndrome. Transthyretin cardiac amyloidosis (CA) is an underdiagnosed cause of HFpEF. Red flags are extremely useful for suspecting CA.

AIMS

We aimed to evaluate the frequency of cardiac and extracardiac manifestations of CA in HFpEF patients based on red flags.

METHODS

Baseline characteristics of 85 patients were recorded during admission. Electrocardiogram and echocardiography were performed. All patients were examined for red flags. Cardiac scintigraphy was performed in 85 patients.

RESULTS

The mean (standard deviation [SD]) age of the study group was 67.9 (9.8) years, and 52 (61.2%) patients were female. At least 1 red flag was observed in 67% of HFpEF patients. Only 4 of the patients had more than 3 red flags. The mean number of red flags in a patient with HFpEF was 1.3. Extracardiac clinical red flags were observed in only 9 (10.5%) patients. Cardiac clinical red flags were extremely rare. An electrocardiographic red flag was detected in 2 out of 10 patients and an echocardiographic red flag in 4 out of 10 patients with HFpEF. Scintigraphy showed that 17.6% of all patients have had a grade 2 or 3 cardiac uptake. The patients with wild-type transthyretin CA had twice as many red flags as those without.

CONCLUSION

The results of the study showed that patients diagnosed with HFpEF had an average of 1.3 red flags suggestive of CA. In real life, extracardiac red flags are rare, while electrocardiographic and echocardiographic red flags are more common in patients with HFpEF.

摘要

背景

射血分数保留的心力衰竭(HFpEF)是一种异质性临床综合征。转甲状腺素蛋白心脏淀粉样变性(CA)是 HFpEF 的一种未被充分诊断的病因。危险信号对于怀疑 CA 非常有用。

目的

我们旨在根据危险信号评估 HFpEF 患者 CA 的心脏和心脏外表现的频率。

方法

在入院期间记录了 85 名患者的基线特征。进行心电图和超声心动图检查。对所有患者进行了危险信号检查。对 85 名患者进行了心脏闪烁显像。

结果

研究组的平均(标准差 [SD])年龄为 67.9(9.8)岁,52 名(61.2%)患者为女性。HFpEF 患者中有 67%观察到至少 1 个危险信号。只有 4 名患者有超过 3 个危险信号。HFpEF 患者的平均危险信号数为 1.3。仅在 9 名(10.5%)患者中观察到心脏外临床危险信号。非常罕见的有心脏临床危险信号。在 10 名 HFpEF 患者中有 2 名心电图出现危险信号,有 4 名超声心动图出现危险信号。闪烁显像显示,所有患者中有 17.6%存在 2 级或 3 级心脏摄取。野生型转甲状腺素蛋白 CA 患者的危险信号是无 CA 患者的两倍。

结论

研究结果表明,诊断为 HFpEF 的患者平均有 1.3 个提示 CA 的危险信号。在现实生活中,心脏外危险信号很少见,而心电图和超声心动图危险信号在 HFpEF 患者中更为常见。

相似文献

1
Assessment of clinical characteristics of cardiac amyloidosis as a potential underlying etiology in patients diagnosed with heart failure with preserved ejection fraction.评估心力衰竭伴射血分数保留患者中心肌淀粉样变作为潜在潜在病因的临床特征。
Kardiol Pol. 2022;80(6):672-678. doi: 10.33963/KP.a2022.0098. Epub 2022 Apr 7.
2
The Most Predictive Red Flags for Suspecting Cardiac Amyloidosis in Patients with Heart Failure with Preserved Ejection Fraction.心力衰竭伴射血分数保留患者疑诊心脏淀粉样变性的最具预测性的危险信号。
Turk Kardiyol Dern Ars. 2024 Jun;52(4):227-236. doi: 10.5543/tkda.2024.33046.
3
Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study.野生型转甲状腺素蛋白心脏淀粉样变在老年人群中并不罕见:CATCH 筛查研究。
Eur J Prev Cardiol. 2024 Aug 22;31(11):1410-1417. doi: 10.1093/eurjpc/zwae093.
4
Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction.野生型转甲状腺素蛋白淀粉样变性导致射血分数保留的心力衰竭。
Eur Heart J. 2015 Oct 7;36(38):2585-94. doi: 10.1093/eurheartj/ehv338. Epub 2015 Jul 28.
5
Transthyretin Cardiac Amyloidosis: An Evolution in Diagnosis and Management of an "Old" Disease.转甲状腺素蛋白心脏淀粉样变:一种“古老”疾病的诊断和治疗的演变。
Cardiol Clin. 2022 Nov;40(4):541-558. doi: 10.1016/j.ccl.2022.06.008. Epub 2022 Sep 15.
6
The Impact of Patients With Cardiac Amyloidosis in HFpEF Trials.心力衰竭伴射血分数保留型(HFpEF)患者临床试验中心脏淀粉样变的影响。
JACC Heart Fail. 2021 Mar;9(3):169-178. doi: 10.1016/j.jchf.2020.12.005. Epub 2021 Feb 3.
7
Value of the HFA-PEFF and H FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis.心脏淀粉样变所致射血分数保留心力衰竭患者的 HFA-PEFF 和 H FPEF 评分的价值。
Eur J Heart Fail. 2022 Dec;24(12):2374-2386. doi: 10.1002/ejhf.2616. Epub 2022 Aug 15.
8
Wild type transthyretin cardiac amiloidozis as a rare and overlooked underlying etiology in a patient with heart failure with preserved ejection fraction and left ventricular hypertrophy.野生型转甲状腺素蛋白心脏淀粉样变性是射血分数保留的心力衰竭和左心室肥厚患者中一种罕见且易被忽视的潜在病因。
Turk Kardiyol Dern Ars. 2021 Oct;49(7):579-584. doi: 10.5543/tkda.2021.09310.
9
Identification of wild-type transthyretin cardiac amyloidosis in patients with carpal tunnel syndrome surgery (CACTuS).在腕管综合征手术(CACTuS)患者中鉴定野生型转甲状腺素蛋白心脏淀粉样变性。
ESC Heart Fail. 2023 Feb;10(1):234-244. doi: 10.1002/ehf2.14173. Epub 2022 Oct 3.
10
Pilot study for left ventricular imaging phenotype of patients over 65 years old with heart failure and preserved ejection fraction: the high prevalence of amyloid cardiomyopathy.65岁以上射血分数保留的心力衰竭患者左心室成像表型的初步研究:淀粉样心肌病的高患病率
Int J Cardiovasc Imaging. 2016 Sep;32(9):1403-1413. doi: 10.1007/s10554-016-0915-z. Epub 2016 May 30.

引用本文的文献

1
Advances and challenges in echocardiographic diagnosis and management of cardiac amyloidosis.心脏淀粉样变性的超声心动图诊断与管理的进展及挑战
Int J Cardiovasc Imaging. 2025 Feb 26. doi: 10.1007/s10554-025-03362-5.
2
Current barriers and recommendations on the diagnosis of transthyretin amyloid cardiomyopathy: a Delphi study.转甲状腺素蛋白淀粉样变心肌病诊断的当前障碍与建议:一项德尔菲研究
Front Cardiovasc Med. 2024 Jan 25;11:1299261. doi: 10.3389/fcvm.2024.1299261. eCollection 2024.